enVVeno Medical (NVNO) Competitors $2.84 +0.15 (+5.37%) As of 03:37 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends NVNO vs. DRTS, UTMD, ARAY, CATX, BWAY, TLSI, SKIN, LNSR, OBIO, and INFUShould you be buying enVVeno Medical stock or one of its competitors? The main competitors of enVVeno Medical include Alpha Tau Medical (DRTS), Utah Medical Products (UTMD), Accuray (ARAY), Perspective Therapeutics (CATX), BrainsWay (BWAY), TriSalus Life Sciences (TLSI), Beauty Health (SKIN), LENSAR (LNSR), Orchestra BioMed (OBIO), and InfuSystem (INFU). These companies are all part of the "surgical & medical instruments" industry. enVVeno Medical vs. Alpha Tau Medical Utah Medical Products Accuray Perspective Therapeutics BrainsWay TriSalus Life Sciences Beauty Health LENSAR Orchestra BioMed InfuSystem enVVeno Medical (NASDAQ:NVNO) and Alpha Tau Medical (NASDAQ:DRTS) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, profitability, analyst recommendations, community ranking, risk, dividends, earnings and valuation. Which has higher earnings and valuation, NVNO or DRTS? Alpha Tau Medical is trading at a lower price-to-earnings ratio than enVVeno Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioenVVeno MedicalN/AN/A-$23.52M-$1.27-2.24Alpha Tau MedicalN/AN/A-$29.16M-$0.43-6.10 Which has more volatility and risk, NVNO or DRTS? enVVeno Medical has a beta of 1.38, meaning that its share price is 38% more volatile than the S&P 500. Comparatively, Alpha Tau Medical has a beta of 0.87, meaning that its share price is 13% less volatile than the S&P 500. Do analysts recommend NVNO or DRTS? Alpha Tau Medical has a consensus target price of $8.00, indicating a potential upside of 205.23%. Given Alpha Tau Medical's stronger consensus rating and higher probable upside, analysts clearly believe Alpha Tau Medical is more favorable than enVVeno Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score enVVeno Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Alpha Tau Medical 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals & insiders hold more shares of NVNO or DRTS? 34.7% of enVVeno Medical shares are owned by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are owned by institutional investors. 16.0% of enVVeno Medical shares are owned by insiders. Comparatively, 39.5% of Alpha Tau Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Does the MarketBeat Community prefer NVNO or DRTS? enVVeno Medical received 137 more outperform votes than Alpha Tau Medical when rated by MarketBeat users. However, 70.37% of users gave Alpha Tau Medical an outperform vote while only 62.65% of users gave enVVeno Medical an outperform vote. CompanyUnderperformOutperformenVVeno MedicalOutperform Votes15662.65% Underperform Votes9337.35% Alpha Tau MedicalOutperform Votes1970.37% Underperform Votes829.63% Is NVNO or DRTS more profitable? Alpha Tau Medical's return on equity of -38.62% beat enVVeno Medical's return on equity.Company Net Margins Return on Equity Return on Assets enVVeno MedicalN/A -48.72% -45.96% Alpha Tau Medical N/A -38.62%-29.89% Does the media favor NVNO or DRTS? In the previous week, enVVeno Medical's average media sentiment score of 0.00 equaled Alpha Tau Medical'saverage media sentiment score. Company Overall Sentiment enVVeno Medical Neutral Alpha Tau Medical Neutral SummaryAlpha Tau Medical beats enVVeno Medical on 8 of the 13 factors compared between the two stocks. Remove Ads Get enVVeno Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for NVNO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NVNO vs. The Competition Export to ExcelMetricenVVeno MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$49.89M$4.31B$5.69B$8.07BDividend YieldN/A39.84%4.89%4.02%P/E Ratio-2.2128.2924.9119.04Price / SalesN/A48.51382.71118.19Price / CashN/A51.0838.0534.62Price / Book0.826.056.884.22Net Income-$23.52M$67.09M$3.19B$246.59M7 Day Performance-5.48%1.94%-0.44%-1.43%1 Month Performance-6.11%-8.38%-6.54%-8.59%1 Year Performance-56.10%17.43%9.06%0.51% enVVeno Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NVNOenVVeno MedicalN/A$2.85+5.4%N/A-57.2%$49.89MN/A-2.2119DRTSAlpha Tau Medical2.1326 of 5 stars$2.91-3.6%$8.00+174.9%-12.6%$203.48MN/A-6.7780UTMDUtah Medical Products1.8501 of 5 stars$59.23-0.6%N/A-15.5%$200.91M$40.90M14.99180Positive NewsARAYAccuray2.9241 of 5 stars$1.92-4.5%N/A-38.3%$197.44M$453.14M-38.401,040CATXPerspective Therapeutics3.1215 of 5 stars$2.46-11.5%$15.14+515.6%N/A$187.90M$1.43M0.0070Analyst UpgradeNews CoverageBWAYBrainsWay3.1344 of 5 stars$9.34-2.2%$13.17+41.0%+54.7%$175.74M$38.63M93.41120Earnings ReportNews CoverageGap UpTLSITriSalus Life Sciences3.2809 of 5 stars$5.65-1.9%$11.56+104.6%-53.4%$172.29M$26.89M-2.27106Positive NewsSKINBeauty Health1.8012 of 5 stars$1.28-13.3%$2.55+100.0%-64.3%$158.26M$347.62M-3.041,030Upcoming EarningsLNSRLENSAR1.807 of 5 stars$13.48+3.7%$16.00+18.7%+217.1%$156.57M$48.87M-9.23110High Trading VolumeOBIOOrchestra BioMed2.0073 of 5 stars$4.10-12.6%$16.25+296.3%-36.5%$155.86M$2.65M-2.554Analyst ForecastINFUInfuSystem1.4547 of 5 stars$7.26-9.0%$13.00+79.1%N/A$154.38M$132.78M121.02410 Remove Ads Related Companies and Tools Related Companies DRTS Alternatives UTMD Alternatives ARAY Alternatives CATX Alternatives BWAY Alternatives TLSI Alternatives SKIN Alternatives LNSR Alternatives OBIO Alternatives INFU Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NVNO) was last updated on 3/11/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding enVVeno Medical Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share enVVeno Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NVNO Stock Alerts